These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20846265)

  • 1. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
    Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
    Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis.
    Ueda J; Semba S; Chiba H; Sawada N; Seo Y; Kasuga M; Yokozaki H
    Pathobiology; 2007; 74(1):32-41. PubMed ID: 17496431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
    Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
    J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
    Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
    Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
    Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Takahashi K; Saito T
    Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis is a new promising prognostic factor in colorectal cancer.
    Pollheimer MJ; Kornprat P; Lindtner RA; Harbaum L; Schlemmer A; Rehak P; Langner C
    Hum Pathol; 2010 Dec; 41(12):1749-57. PubMed ID: 20869096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma.
    Turunen M; Talvensaari-Mattila A; Soini Y; Santala M
    Anticancer Res; 2009 Dec; 29(12):5185-9. PubMed ID: 20044634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
    Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
    J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer.
    Shibutani M; Noda E; Maeda K; Nagahara H; Ohtani H; Hirakawa K
    Anticancer Res; 2013 Aug; 33(8):3301-6. PubMed ID: 23898096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster analysis of claudin-1 and -4, E-cadherin, and β-catenin expression in colorectal cancers.
    Matsuoka T; Mitomi H; Fukui N; Kanazawa H; Saito T; Hayashi T; Yao T
    J Surg Oncol; 2011 Jun; 103(7):674-86. PubMed ID: 21360533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer.
    Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ
    J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
    Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
    Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.